Zobrazeno 1 - 10
of 16
pro vyhledávání: '"D. J. Biedenbach"'
Publikováno v:
Антибиотики и Химиотерапия, Vol 60, Iss 11-12, Pp 51-51 (2020)
Externí odkaz:
https://doaj.org/article/9f986feb091b4891a645826f6595def6
Publikováno v:
Diagnostic microbiology and infectious disease. 35(4)
The introduction of cephalosporins has had an important impact on the resistance rates to several clinically utilized beta-lactam antimicrobial agents. Most Thailand medical centers have not documented the levels of emerging resistant pathogens causi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cb5d329ad3ad2c7fe2abb6410e63d384
https://pubmed.ncbi.nlm.nih.gov/10668592
https://pubmed.ncbi.nlm.nih.gov/10668592
Publikováno v:
Diagnostic microbiology and infectious disease. 35(4)
The rates of resistance to commonly used antimicrobial agents have been documented to be at alarmingly high levels in Taiwan for both Gram-positive and Gram-negative species. This study was conducted to assess the current resistance patterns in six m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::194a8d251321b247a765affcd9b3449e
https://pubmed.ncbi.nlm.nih.gov/10668589
https://pubmed.ncbi.nlm.nih.gov/10668589
Publikováno v:
Diagnostic microbiology and infectious disease. 35(4)
The in vitro activity of cefepime and six other broad-spectrum beta-lactams (cefpirome, ceftazidime, ceftriaxone, imipenem, piperacillin/tazobactam (4 micrograms/mL fixed concentration), and oxacillin was evaluated against 191 isolates of clinical ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ecd107c631cc2d5261ef3c8ae27b7a2f
https://pubmed.ncbi.nlm.nih.gov/10668587
https://pubmed.ncbi.nlm.nih.gov/10668587
Publikováno v:
Diagnostic microbiology and infectious disease. 35(4)
The degree of activity of several beta-lactam antimicrobial agents was assessed in Malaysia (four medical centers) and Singapore (two medical centers) tested against 570 clinical isolates. The organisms were tested locally by the Etest (AB BIODISK, S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fda5493854e8dfc20696e64e942ebda5
https://pubmed.ncbi.nlm.nih.gov/10668586
https://pubmed.ncbi.nlm.nih.gov/10668586
Publikováno v:
Diagnostic microbiology and infectious disease. 35(4)
Levels of resistance to the "third-generation" cephalosporins among isolates of clinical bacteria in Korea have been increasing at a rapid rate. This study evaluated the activity of cefepime, a "fourth-generation" cephalosporin, and six other broad-s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dbc476f3fb58f8451cfd978dbf6fcd89
https://pubmed.ncbi.nlm.nih.gov/10668591
https://pubmed.ncbi.nlm.nih.gov/10668591
Publikováno v:
Diagnostic microbiology and infectious disease. 35(4)
Cefepime is a potent broad-spectrum "fourth-generation" cephalosporin. The in vitro activity of cefepime was compared to that of cefpirome, ceftazidime, ceftriaxone, imipenem, and piperacillin/tazobactam in a multilaboratory (nine medical centers) Ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cb251eb7db8a4f09060317022669d36f
https://pubmed.ncbi.nlm.nih.gov/10668588
https://pubmed.ncbi.nlm.nih.gov/10668588
Publikováno v:
Diagnostic microbiology and infectious disease. 35(2)
A surveillance study was initiated in China in 1998 in which 10 medical centers participated. The susceptibility profiles of 996 commonly occurring pathogens belonging to 10 different species groups were tested by the Etest (AB BIODISK, Solna, Sweden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9bf3deea62534c4847d776165da90bd2
https://pubmed.ncbi.nlm.nih.gov/10579094
https://pubmed.ncbi.nlm.nih.gov/10579094
Publikováno v:
Diagnostic microbiology and infectious disease. 34(2)
Gatifloxacin (formerly AM-1155 or CG 5501) is a new 8-methoxy fluoroquinolone with enhanced activity against Gram-positive cocci, especially Streptococcus pneumoniae and other streptococci. Recent clinical strains (599 isolates) were tested against g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9d9aec66d117a5126f7f9ab1e59ef581
https://pubmed.ncbi.nlm.nih.gov/10354857
https://pubmed.ncbi.nlm.nih.gov/10354857
Publikováno v:
Diagnostic microbiology and infectious disease. 33(4)
Gatifloxacin (formerly AM-1155 and CG5501), a new 8-methoxy fluoroquinolone, has an expanded spectrum of activity against Gram-positive cocci and some anaerobic bacteria. This compound was tested against 600 recent clinical strains of rapidly growing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a0b527d8e6d1b1cc608df0047ad8934a
https://pubmed.ncbi.nlm.nih.gov/10212751
https://pubmed.ncbi.nlm.nih.gov/10212751